Search results
Results from the WOW.Com Content Network
The Kennedy Krieger Institute (/ ˈ k r iː ɡ ər /) is a nonprofit, 501(c)(3) tax-exempt, Johns Hopkins Hospital affiliate located in Baltimore, Maryland, that provides in-patient and out-patient medical care, community services, and school-based programs for children and adolescents with learning disabilities, [1] as well as disorders of the brain, spinal cord, and musculoskeletal system.
Rebecca Jean Moellman-Landa (born 1955) is an American speech-language pathologist specializing in neuropsychology and autism research. She is the founder and director of the center for autism and related disorders at the Kennedy Krieger Institute. Landa is a professor of psychiatry and behavioral sciences at the Johns Hopkins School of Medicine.
The Autism Informatics Consortium (AIC) was launched in 2011 with the goal of accelerating scientific discovery by making informatics tools and resources more useful to autism researchers. Current members include Autism Speaks, Kennedy Krieger Institute, Simons Foundation, Prometheus Research, and the NIH. [5]
Trump has announced Robert F. Kennedy Jr., who has previously stated that vaccines cause autism, as his nominee for the Department of Health and Human Services Secretary, NPR reported. Trump said ...
President-elect Trump suggested in an interview Sunday that Robert F. Kennedy Jr., his pick to lead the Department of Health and Human Services, would investigate a debunked link between vaccines ...
The Kennedy Krieger Institute is a branch of Johns Hopkins that provides medical care, rehabilitation, and research, especially emphasizing research geared towards children with learning and physical disabilities arising from neurodegenerative disorders. Lead's effects on the nervous system manifests into reduced cognitive ability, especially ...
The Transporters is a 2006 children's animation series produced by Catalyst Pictures Limited designed to help children with autism aged between 2 and 8 years old recognise and understand emotions. It was developed by the Autism Research Centre at the University of Cambridge by a team led by Professor Simon Baron-Cohen and including Dr Ofer Golan.
Erika F. Augustine is an Associate Chief Science Officer and Director of the Clinical Trials Unit at Kennedy Krieger Institute. She was previously an Associate Professor of Neurology and Pediatrics at the University of Rochester Medical Center in Rochester, New York.